GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled Study
NCT ID: NCT00515840
Last Updated: 2015-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
182 participants
INTERVENTIONAL
2003-10-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To investigate the effects of breathing retraining on clinical and physiological parameters of asthma control, to identify the characteristics of patients who benefit, to perform a health economic evaluation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Minimal Intervention Educational Program in the Asthma Control and Exacerbations Prevention
NCT01282359
Lysophosphatidylglycerol in Asthma Pathogenesis
NCT06327516
Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes
NCT02140671
Effects of Regular Submaximal Exercise on Asthma Control and Quality of Life in Patients With Persistent Symptoms
NCT04395937
Assessment of Activity Limitation in Asthma Patients
NCT01962142
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To assess the effect of breathing retraining on asthma-related health status, asthma control and objective indices of asthma severity (bronchial hyper-reactivity (BHR), sputum eosinophilia and nitric oxide production) in patients with symptomatic asthma.
* To compare the relationship between symptoms of dysfunctional breathing (Nijmegen Questionnaire screening score), changes in asthma-related health status and other parameters resulting from breathing retraining
* To explore the relationship between dysfunctional breathing, baseline asthma symptoms, treatment and asthma-related quality of life.
* To estimate the cost effectiveness of the breathing retraining intervention
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
equal time with health care professional (asthma nurse)
Physiotherapist
Physiotherapist administered breathing retraining programme
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physiotherapist
Physiotherapist administered breathing retraining programme
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 17-70 yrs.
* One or more prescription for asthma medication in previous 12 months
* Impaired asthma related quality of life (AQLQ score \<5.5)
Exclusion Criteria
* Unstable or under-treated asthma at enrollment.
17 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospitals, Leicester
OTHER
P Burns
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
P Burns
Research Governance Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mike Thomas
Role: PRINCIPAL_INVESTIGATOR
University of Aberdeen
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03/014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.